Management of Locally Advanced Lung Cancer

Hak Choy, Jameson Travis Mendel

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Lung cancer remains the leading cause of cancer mortality, accounting for one-quarter of all cancer deaths per year. Smoking continues to be one of the leading causes of lung cancer, and screening in high-risk populations with low-dose computed tomography has been shown to decrease relative mortality. Management of locally advanced lung cancer necessitates multimodality treatment, requiring cooperation and coordination among thoracic surgery, medical oncology, and radiation oncology. Over the years, substantial improvements in treatment techniques have led to significant improvements in overall survival for patients with locally advanced non-small-cell lung cancer. Targeted agents and immunotherapies are an exciting frontier in systemic treatment options and will likely play an important role in future management.

Original languageEnglish (US)
Title of host publicationPulmonary Adenocarcinoma
Subtitle of host publicationApproaches to Treatment
PublisherElsevier
Pages57-86
Number of pages30
ISBN (Electronic)9780323554336
DOIs
StatePublished - Jan 1 2018

Keywords

  • Chemotherapy
  • Immunotherapy
  • Locally advanced non-small-cell lung cancer
  • Medical oncology
  • Oncology
  • Radiation
  • Targeted therapy
  • Thoracic surgery

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Management of Locally Advanced Lung Cancer'. Together they form a unique fingerprint.

Cite this